Reported Feb 19, 2020 · Terminated

Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay,…

Taro Pharmaceuticals U.S.A., Inc.

High riskUsing this product could cause serious injury, illness or death — stop using it now.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Taro Pharmaceuticals U.S.A., Inc. · 3 Skyline Dr · Hawthorne, NY · 10532-2174

Is this the product you have?

  • Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd
  • byTaro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist
  • byTaro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1
Lot codes and dates
    • Lot #: 331771
    • Exp. June 2021

Where it was sold

  • Nationwide
  • PR

Why it was recalled

Stop using this product now

Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.

Using this product could cause serious injury, illness or death — stop using it now.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Taro Pharmaceuticals U.S.A., Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Feb 23, 2024 · Data as of Sep 19, 7:18 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.